We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$159M
AUM Growth
-$13M
Cap. Flow
-$34.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
22.04%
Holding
189
New
40
Increased
46
Reduced
55
Closed
32

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$1.24M
2
ARW icon
Arrow Electronics
ARW
+$1.12M
3
IDXX icon
Idexx Laboratories
IDXX
+$918K
4
ROL icon
Rollins
ROL
+$908K
5
DHR icon
Danaher
DHR
+$906K

Top Sells

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$2.66M
2
WMT icon
Walmart Inc
WMT
+$2.1M
3
CHRW icon
C.H. Robinson
CHRW
+$1.39M
4
ABT icon
Abbott
ABT
+$1.31M
5
AME icon
Ametek
AME
+$1.26M

Sector Composition

Rank Sector Weight
1 Industrials 21.35%
2 Healthcare 19.44%
3 Financials 12.65%
4 Consumer Staples 12.28%
5 Technology 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
76
Toronto Dominion Bank
TD
$199B
$685K 0.43%
11,175
-100
-0.9% -$6.47K
AMD icon
77
Advanced Micro Devices
AMD
$823B
$674K 0.42%
10,636
+2,325
+28% +$198K
BAX icon
78
Baxter International
BAX
$12.3B
$674K 0.42%
12,515
-200
-2% -$12K
MET icon
79
MetLife
MET
$62.4B
$672K 0.42%
11,050
-350
-3% -$22.4K
REGN icon
80
Regeneron Pharmaceuticals
REGN
$79.7B
$642K 0.4%
932
-59
-6% -$37.1K
LYB icon
81
LyondellBasell Industries
LYB
$21.1B
$640K 0.4%
8,500
-100
-1% -$8.45K
PYPL icon
82
PayPal
PYPL
$46B
$633K 0.4%
7,350
+2,089
+40% +$185K
GIS icon
83
General Mills
GIS
$19.6B
$622K 0.39%
8,125
-50
-0.6% -$3.81K
CL icon
84
Colgate-Palmolive
CL
$69.4B
$621K 0.39%
8,838
-100
-1% -$7.84K
AMZN icon
85
Amazon
AMZN
$2.68T
$619K 0.39%
+5,475
New +$692K
ABB
86
DELISTED
ABB Ltd
ABB
$599K 0.38%
+23,350
New +$656K
MHK icon
87
Mohawk Industries
MHK
$8.74B
$597K 0.38%
+6,550
New +$760K
DAR icon
88
Darling Ingredients
DAR
$10.5B
$587K 0.37%
8,875
-1,550
-15% -$108K
DD icon
89
DuPont de Nemours
DD
$17.3B
$575K 0.36%
9,095
-92
-1% -$6.57K
QCOM icon
90
Qualcomm
QCOM
$201B
$565K 0.36%
5,000
-4,135
-45% -$568K
CMI icon
91
Cummins
CMI
$74.1B
$560K 0.35%
+2,750
New +$585K
KR icon
92
Kroger
KR
$37.1B
$549K 0.35%
+12,555
New +$596K
TDG icon
93
TransDigm Group
TDG
$60B
$548K 0.35%
1,045
-340
-25% -$203K
AR icon
94
Antero Resources
AR
$11.9B
$539K 0.34%
+17,650
New +$652K
IR icon
95
Ingersoll Rand
IR
$27.9B
$534K 0.34%
12,350
SBUX icon
96
Starbucks
SBUX
$110B
$526K 0.33%
6,245
-3,445
-36% -$293K
AWK icon
97
American Water Works
AWK
$27.4B
$514K 0.32%
+3,950
New +$595K
CE icon
98
Celanese
CE
$5.18B
$497K 0.31%
+5,500
New +$604K
CB icon
99
Chubb
CB
$132B
$487K 0.31%
+2,680
New +$509K
COP icon
100
ConocoPhillips
COP
$170B
$484K 0.3%
+4,725
New +$471K

Similar funds

New England Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, New England Research & Management held 189 positions worth $159M, down 7.6% from $172M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2022 filing shows 40 new, 46 increased, 55 reduced and 32 closed positions. Its largest new stake was United Therapeutics: 5,550 shares worth $1.16M. The largest sale was Cheniere Energy, an estimated $2.66M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2022 buy was United Therapeutics: 5,550 shares worth $1.16M.
  • New England Research & Management added most to Coca-Cola in Q3 2022, an estimated $817K increase.
  • New England Research & Management's biggest Q3 2022 reduction was Walmart Inc, cutting an estimated $2.1M.
  • New England Research & Management fully exited Cheniere Energy in Q3 2022, selling an estimated $2.66M.
  • New England Research & Management's ten largest holdings make up 22% of its $159M portfolio in Q3 2022.
  • New England Research & Management opened 40 new positions and closed 32 in Q3 2022.
  • New England Research & Management's portfolio value fell 7.6% quarter-over-quarter to $159M.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.